{'fraction_non_alphanumeric': 0.013182674199623353, 'fraction_numerical': 0.0, 'mean_word_length': 5.409638554216867, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Estimating the benefits of adjuvant systemic therapy for women with early breast cancer

Prognostic factors are commonly used to help identify women with node‐negative breast cancer at high risk of recurrence. Although many are available, knowing which risk factor or combination of factors to use to estimate prognosis for an individual woman is often difficult. This study documented the baseline prognoses for a group of women with node‐negative breast cancers, and estimated the potential benefits of adjuvant systemic therapy.